BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

OLIGOMERIX 

Audubon Business and Technology Center
Columbia University Medical Center

3960 Broadway, Suite 440C
New York  New York  10032  U.S.A.
Phone: 212-568-0365 Fax: 212-568-0469


SEARCH JOBS



Segment
Start Up





 Company News
OLIGOMERIX To Present At Biotech Showcase™ 2014 1/7/2014 8:41:47 AM    More...
Taconic And OLIGOMERIX To Collaborate On Tau Mouse Model Characterization For Use In Alzheimer's Disease Research 12/9/2013 11:12:28 AM    More...
OLIGOMERIX Awarded Phase IIB Grant From the NIH to Discover Drugs That Inhibit Alzheimer's Disease Progression 9/10/2013 10:50:16 AM    More...
OLIGOMERIX Release: Identification of a Tau Oligomer Structure That is Toxic to Neurons Published in the International Journal of Cell Biology 9/4/2013 10:43:56 AM    More...
OLIGOMERIX Announces Addition of Industry Veteran James Hendrix, Ph.D., to Serve as Senior Director of Chemistry 7/16/2013 10:05:23 AM    More...
OLIGOMERIX to Present Multiple Posters Highlighting its Tau-Focused Technology During the Annual Alzheimer's Association International Conference® 7/9/2013 6:34:53 AM    More...
OLIGOMERIX Completes Series B Financing 5/22/2013 10:22:49 AM    More...
OLIGOMERIX Completes $2 Million Series A Financing 4/23/2012 10:25:33 AM    More...
A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by OLIGOMERIX at the Society For Neuroscience Annual Meeting 11/17/2011 11:43:47 AM    More...
OLIGOMERIX Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer 10/13/2010 10:40:28 AM    More...
12

//-->